- Home
- VCRE vs SOR Comparison
VCRE vs SOR Comparison
Compare VCRE & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | VCRE | SOR |
|---|---|---|
| Founded | N/A | N/A |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.9M | 383.4M |
| IPO Year | 2026 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VCRE | SOR |
|---|---|---|
| Price | $11.07 | $46.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.7K | ★ 10.1K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.50 | $44.20 |
| 52 Week High | $13.15 | $50.41 |
Technical Indicators
Market Signals| Indicator | VCRE | SOR |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 64.09 |
| Support Level | $10.83 | $47.45 |
| Resistance Level | $13.00 | $48.44 |
| Average True Range (ATR) | 0.73 | 0.57 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 20.00 | 100.00 |
Price Performance
Historical ComparisonAbout VCRE Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.